Outpatient Ultrafiltration Therapy in Heart Failure Patients Trial

Sponsor
Hennepin Healthcare Research Institute (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00319384
Collaborator
Nuwellis, Inc. (Industry)
0
1
13
0

Study Details

Study Description

Brief Summary

This trial will look at the effectiveness and patient acceptance of ultrafiltration therapy in an outpatient setting.

The purpose of this study is to determine if ambulatory patients who suffer from heart failure and hypervolemia can be safely and effectively treated in an outpatient infusion clinic. The results from this trial will be useful in planning a larger, randomized trial comparing usual care and ultrafiltration for this patient population in similar ambulatory settings.

Condition or Disease Intervention/Treatment Phase
  • Device: Ultrafiltration therapy
N/A

Detailed Description

This is a pilot study to assess the feasibility, effectiveness, safety and patient acceptance of ultrafiltration in ambulatory patients with heart failure and hypervolemia. The results will be useful in planning a larger clinical trial.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Outpatient Ultrafiltration Therapy in Heart Failure Feasibility Trial
Study Start Date :
Apr 1, 2006
Anticipated Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Efficacy []

  2. The primary efficacy endpoint is weight loss measured immediately and 48 hours after ultrafiltration. []

Secondary Outcome Measures

  1. Quality of life will be assessed by the NYHA classification at 48 hours. []

  2. Likert scales addressing global heart failure and shortness of breath symptoms at 48 hours. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients will be recruited from the cardiology clinic at Hennepin County Medical
Center. Patients are eligible for the study if they are:
  1. Older than 18

  2. Not pregnant

  3. Have heart failure with worsening hypervolemia despite oral diuretics

  4. Have at least two of the following signs or symptoms of hypervolemia: JVD, edema

1+, rales pulmonary edema on chest x-ray, orthopnea or PND

  1. Not more than 10 kg above their usual baseline weight

  2. Have, in the opinion of the treating physician, a need for a minimum of 2 liters of volume removal

Exclusion Criteria:
  1. Systolic blood pressure < 90 mmHg

  2. Serum creatinine > 3.0 mg/dL

  3. Hematocrit >45 %

  4. Uncontrolled arrhythmias

  5. Need for hospitalization

  6. Require renal replacement therapy

  7. Contraindication to anticoagulation with heparin

  8. Poor venous access.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hennepin County Medical Center Minneapolis Minnesota United States 55415

Sponsors and Collaborators

  • Hennepin Healthcare Research Institute
  • Nuwellis, Inc.

Investigators

  • Principal Investigator: Bradley Bart, MD, Hennepin Faculty Associates

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00319384
Other Study ID Numbers:
  • HSR 06-2642
First Posted:
Apr 27, 2006
Last Update Posted:
Oct 4, 2012
Last Verified:
Oct 1, 2012
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2012